Skip to main content

ADVERTISEMENT

Kellie Rademacher, PharmD

Pharma Insights
12/13/2017
Kellie Rademacher, PharmD
Todd Edgar, PharmD, MS
12/13/2017
Journal of Clinical Pathways
Pharma Insights
10/16/2017
Kellie Rademacher, PharmD
Hetty A Lima, BSPharm, RPh, FASHP
New drugs for orphan and rare diseases have the potential to positively impact the lives of patients where historically few or no treatments had been available to manage the disease. The passage of the Orphan Drug...
New drugs for orphan and rare diseases have the potential to positively impact the lives of patients where historically few or no treatments had been available to manage the disease. The passage of the Orphan Drug...
New...
10/16/2017
Journal of Clinical Pathways